SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC14D9C - Written communication relating to third party tender offer:
SEC Accession No. 0001104659-23-106471
Filing Date
2023-10-03
Accepted
2023-10-03 17:24:13
Documents
9

Document Format Files

Seq Description Document Type Size
1 SC14D9C tm2327397d3_sc14d9c.htm SC14D9C 22053
2 EXHIBIT 99.1 tm2327397d3_ex99-1.htm EX-99.1 14436
3 EXHIBIT 99.2 tm2327397d3_ex99-2.htm EX-99.2 44310
4 EXHIBIT 99.3 tm2327397d3_ex99-3.htm EX-99.3 18780
5 EXHIBIT 99.4 tm2327397d3_ex99-4.htm EX-99.4 12344
6 EXHIBIT 99.5 tm2327397d3_ex99-5.htm EX-99.5 11853
7 EXHIBIT 99.6 tm2327397d3_ex99-6.htm EX-99.6 12091
8 EXHIBIT 99.7 tm2327397d3_ex99-7.htm EX-99.7 12291
9 EXHIBIT 99.8 tm2327397d3_ex99-8.htm EX-99.8 11781
  Complete submission text file 0001104659-23-106471.txt   161624
Mailing Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268
Business Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 (317) 543-9957
POINT Biopharma Global Inc. (Filed by) CIK: 0001811764 (see all company filings)

IRS No.: 850800493 | Fiscal Year End: 1231
Type: SC14D9C
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268
Business Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 (317) 543-9957
POINT Biopharma Global Inc. (Subject) CIK: 0001811764 (see all company filings)

IRS No.: 850800493 | Fiscal Year End: 1231
Type: SC14D9C | Act: 34 | File No.: 005-91575 | Film No.: 231305509
SIC: 2834 Pharmaceutical Preparations